I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-43.97%
Change (1 year)
Categories
I-Mab Biopharma (IMAB) - Net assets
Net assets on the balance sheet as of June 2023 : $0.33 B
According to I-Mab Biopharma's latest financial reports the company has $0.33 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
I-Mab Biopharma - Net assets on balance sheet (from 2018 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.42 B | -41.04% |
| 2021-12-31 | $0.71 B | -17.06% |
| 2020-12-31 | $0.86 B | -396.21% |
| 2019-12-31 | $-0.3 B | 109.73% |
| 2018-12-31 | $-0.14 B | 201.38% |
| 2017-12-31 | $-46.09 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.38 B | 311.74% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $10.67 M | -96.84% | 🇺🇸 USA |